Takeda Pharmaceutical Income Statement (2017-2026) | TAK

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	8.67B	7.67B	7.93B	8.37B	7.52B	7.26B	7.76B	8.00B	7.72B	7.69B	7.11B	7.09B	7.76B	23.65B	6.92B	7.92B	8.13B	23.95B	7.11B	6.98B
Cost of Revenue (Quarter)	2.20B	2.51B	2.48B	2.52B	2.26B	2.21B	2.38B	2.43B	2.34B	2.63B	2.58B	2.58B	2.49B	8.03B	2.52B	2.54B	2.73B	8.13B	2.64B	2.59B
Gross Profit (Quarter)	6.47B	5.17B	5.45B	5.85B	5.48B	15.71B	4.60B	5.57B	5.17B	5.31B	4.52B	4.51B	5.02B	15.62B	4.40B	5.38B	5.40B	15.81B	4.47B	4.39B
Operating items
Amortization - Intangibles (Quarter)
Research & Development (Quarter)	-1.12B	-1.20B	-1.13B	-1.24B	-1.11B	-1.12B	-1.24B	-1.23B	-1.19B	-1.27B	-1.27B	8.53B	-1.08B	-1.18B	-1.12B	-1.42B	-0.99B	-1.10B	-1.14B	-1.25B
Share-based Compensation (IS) (Quarter)	0.08B	0.11B	0.10B	0.10B	0.10B	0.12B	0.12B	0.11B	0.11B	0.13B	0.13B	0.12B	0.10B	0.14B	0.12B	0.12B	0.11B	0.13B	0.12B	0.13B
Selling, General & Administrative (Quarter)	-2.01B	-1.93B	-2.03B	-1.99B	-1.79B	-1.80B	-1.86B	-1.88B	-1.81B	-1.85B	-1.92B	5.76B	-1.73B	-5.42B	-1.95B	-1.77B	-1.85B	-5.49B	-1.92B	-1.86B
Operating Expenses (Quarter)	-3.13B	-3.12B	-3.16B	-3.23B	-2.90B	-2.92B	-3.09B	-3.11B	-3.00B	-3.13B	-3.19B	14.29B	-2.82B	-6.60B	-3.07B	-3.19B	-2.85B	-6.59B	-3.06B	-3.11B
Operating Income (Quarter)	2.27B	0.89B	1.02B	2.14B	1.16B	0.76B	1.04B	1.27B	1.23B	2.28B	1.58B	-0.07B	1.07B	6.75B	1.25B	2.51B	2.33B	6.83B	1.31B	-0.09B
EBIT (Quarter)	2.27B	0.89B	1.02B	2.14B	1.16B	0.76B	1.04B	1.27B	1.23B	2.28B	1.58B	-0.07B	1.07B	6.75B	1.25B	2.51B	2.33B	6.83B	1.31B	-0.09B
Non-operating items
Interest & Investment Income (Quarter)	0.42B	0.43B	0.38B		0.47B	0.55B	0.39B		0.19B	0.17B	0.31B		0.20B	0.23B	0.18B		0.31B	1.40B	0.10B	1.35B
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)
Net income details
EBT (Quarter)	2.04B	0.56B	0.64B	1.92B	1.20B	0.47B	0.76B	1.18B	0.99B	2.03B	1.42B	-0.32B	0.88B	6.04B	1.03B	2.31B	2.04B	6.12B	1.08B	-0.33B
Tax Provisions (Quarter)	-0.78B	-0.14B	-0.13B	-0.73B	-0.39B	-0.02B	0.08B	-0.38B	-0.33B	-0.22B	-0.34B	-0.93B	-0.27B	-1.36B	-0.29B	-0.50B	-0.58B	-1.37B	-0.29B	-0.18B
Profit After Tax (Quarter)	1.26B	0.42B	0.51B	1.18B	0.81B	0.45B	0.84B	0.79B	0.65B	1.80B	1.08B	-0.02B	0.61B	4.69B	0.74B	1.81B	1.47B	4.74B	0.91B	-0.15B
Equity Income (Quarter)	-0.00B	-0.03B	-0.02B	-0.00B	0.00B	-0.01B	-0.01B	-0.00B	0.00B	0.01B	-0.02B	0.03B	0.00B	0.03B	0.01B	0.00B	0.01B	0.01B	-0.00B	0.03B
Income from Non-Controlling Interests (Quarter)	0.00B	0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B		0.00B			0.00B	0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.00B
Income from Continuing Operations (Quarter)	2.82B	0.70B	0.76B	2.65B	1.59B	0.49B	0.67B	1.56B	1.32B	2.25B	1.76B	0.61B	1.14B	7.40B	1.32B	2.81B	2.62B	7.49B	1.37B	-0.15B
Consolidated Net Income (Quarter)	2.82B	0.70B	0.76B	2.65B	1.59B	0.49B	0.67B	1.56B	1.32B	2.25B	1.76B	0.61B	1.14B	7.40B	1.32B	2.81B	2.62B	7.49B	1.37B	-0.15B
Income towards Parent Company (Quarter)	1.26B	0.42B	0.51B	-0.10B	0.81B	0.45B	0.84B	1.76B	0.65B	1.80B	1.08B	-0.02B	0.61B	4.69B	0.74B	1.81B	1.47B	4.74B	0.91B	-0.16B
Net Income towards Common Stockholders (Quarter)	1.26B	0.42B	0.51B	-0.10B	0.81B	0.45B	0.84B	1.76B	0.65B	1.80B	1.08B	-0.02B	0.61B	4.69B	0.74B	1.81B	1.47B	4.74B	0.91B	-0.16B
Additional items
EPS (Basic) (Quarter)	1.57B	0.39B	0.37B	-7.18	1.55B	0.57B	0.65B	147.51	1.55B	9.83B	1.69B	0.00	1.57B	5.88B	0.85B	0.00B	0.00B	0.00B	1.02B	-0.00B
EPS (Weighted Average and Diluted) (Quarter)	1.57B	0.39B	0.38B	-0.08B	1.55B	0.58B	0.65B	1.16B	1.57B	9.91B	1.71B	-0.03B	1.59B	5.97B	0.86B	4.12B	2.71B	9.92B	1.04B	-0.20B
Shares Outstanding (Weighted Average) (Quarter)	0.80	1.06	1.36	0.01B	0.53	0.78	1.30	0.01B	0.42	0.18	0.64	11.31B	0.39	0.80	0.88	0.00B	0.00B	0.00B	0.89	0.00B
Shares Outstanding (Diluted Average) (Quarter)	0.80	1.06	1.35	1.26	0.52	0.77	1.29	1.53	0.42	0.18	0.63	0.62	0.39	0.79	0.87	0.44	0.54	0.48	0.88	0.76
EBITDA (Quarter)	2.27B	0.89B	1.02B	2.14B	1.16B	0.76B	1.04B	1.27B	1.23B	2.28B	1.58B	-0.07B	1.07B	6.75B	1.25B	2.51B	2.33B	6.83B	1.31B	-0.09B
Interest Expenses (Quarter)	-0.65B	-0.36B	-0.41B	2.67B	-0.43B	-0.39B	-0.56B	-0.41B	-0.43B	-0.53B	-0.28B	2.65B	-0.38B	-1.03B	-0.31B	-0.68B	-0.56B	-2.07B	-0.32B	-0.28B
Tax Rate (Quarter)	-38.23%	-25.15%	-19.91%	-38.25%	-32.45%	-4.36%	11.20%	-32.48%	-33.79%	-10.94%	-24.11%	290.99%	-30.24%	-22.47%	-28.62%	-21.47%	-28.17%	-22.47%	-26.88%	53.78%

Research Tools

Developers

Takeda Pharmaceutical Income Statement (2017-2026) | TAK

Research Tools

Developers

Takeda Pharmaceutical Income Statement (2017-2026) | TAK

Create an account

Sign In

Reset Password